| Patent | Date |
|---|
Modified Fibroblast Growth Factor 1 (fgf-1) Polypeptides With Increased Binding Affinity For Heparin And Associated Methods
App 20210087248 - Blaber; Michael ; et al. | 2021-03-25 |
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20200040051 - Evans; Ronald M. ; et al. | 2020-02-06 |
Modified Fibroblast Growth Factor 1 (fgf-1) Polypeptides With Increased Binding Affinity For Heparin And Associated Methods
App 20180265558 - Blaber; Michael ; et al. | 2018-09-20 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20180230192 - Blaber; Michael ; et al. | 2018-08-16 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 10,022,426 - Blaber , et al. July 17, 2 | 2018-07-17 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 10,000,540 - Blaber , et al. June 19, 2 | 2018-06-19 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 9,957,310 - Blaber , et al. May 1, 2 | 2018-05-01 |
Synthetic Foldable Proteins Generated From Peptide Segments Of Folding Nuclei Of Reference Proteins
App 20170362289 - Blaber; Michael ; et al. | 2017-12-21 |
Fibroblast Growth Factor (fgf) 1 With Mutation In The Heparin Binding Domain And Methods Of Use To Reduce Blood Glucose
App 20170355739 - Evans; Ronald M. ; et al. | 2017-12-14 |
Method for development of a peptide building block useful for de novo protein design
Grant 9,840,544 - Blaber , et al. December 12, 2 | 2017-12-12 |
Synthetic foldable proteins generated from peptide segments of folding nuclei of reference proteins
Grant 9,783,587 - Blaber , et al. October 10, 2 | 2017-10-10 |
Small animal restraining harness or jacket
Grant 9,717,217 - Blaber , et al. August 1, 2 | 2017-08-01 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20170095532 - Blaber; Michael ; et al. | 2017-04-06 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20170096465 - Blaber; Michael ; et al. | 2017-04-06 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20170096464 - Blaber; Michael ; et al. | 2017-04-06 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 9,469,680 - Blaber , et al. October 18, 2 | 2016-10-18 |
Method For Development Of A Peptide Building Block Useful For De Novo Protein Design
App 20150361149 - BLABER; MICHAEL ; et al. | 2015-12-17 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20150148293 - BLABER; MICHAEL ; et al. | 2015-05-28 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 8,962,557 - Blaber , et al. February 24, 2 | 2015-02-24 |
Recombinant Human Fibroblast Growth Factor-1 As A Novel Therapeutic For Ischemic Diseases And Methods Thereof
App 20140045751 - BLABER; Michael | 2014-02-13 |
Methods And Materials For Treating Inflammatory Conditions
App 20130323262 - Scarisbrick; Isobel A. ; et al. | 2013-12-05 |
Fibroblast growth factor mutants having improved functional half-life and methods of their use
Grant 8,461,111 - Blaber , et al. June 11, 2 | 2013-06-11 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20130130983 - BLABER; MICHAEL ; et al. | 2013-05-23 |
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Grant 8,153,771 - Blaber , et al. April 10, 2 | 2012-04-10 |
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Grant 8,153,770 - Blaber , et al. April 10, 2 | 2012-04-10 |
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Grant 8,119,776 - Blaber , et al. February 21, 2 | 2012-02-21 |
Method For Development Of A Peptide Building Block Useful For De Novo Protein Design
App 20110224404 - Blaber; Michael ; et al. | 2011-09-15 |
Methods And Materials For Treating Inflammatory Conditions
App 20110008789 - Scarisbrick; Isobel A. ; et al. | 2011-01-13 |
Fibroblast Growth Factor Mutants Having Improved Functional Half-life And Methods Of Their Use
App 20100298220 - BLABER; MICHAEL ; et al. | 2010-11-25 |
Engineered human acidic fibroblast growth factors and associated methods
Grant 7,790,682 - Blaber , et al. September 7, 2 | 2010-09-07 |
Mutant polypeptides of fibroblast growth factor 1
Grant 7,776,825 - Blaber , et al. August 17, 2 | 2010-08-17 |
Method of treating multiple sclerosis with anti-K6 antibody
Grant 7,754,216 - Scarisbrick , et al. July 13, 2 | 2010-07-13 |
Mutant polypeptides of fibroblast growth factor 1
Grant 7,696,171 - Blaber , et al. April 13, 2 | 2010-04-13 |
Mutants of human fibroblast growth factor having increased stability and/or mitogenic potency
Grant 7,659,379 - Blaber , et al. February 9, 2 | 2010-02-09 |
Mutant polypeptides of fibroblast growth factor 1
Grant 7,595,296 - Blaber , et al. September 29, 2 | 2009-09-29 |
Methods and materials for treating inflammatory conditions
App 20060127391 - Scarisbrick; Isobel A. ; et al. | 2006-06-15 |
Synthetic nucleic acid sequences for 2,5-diketo-D-gluconic acid reductases and associated methods
App 20020146731 - Sanli, Gulsah ; et al. | 2002-10-10 |
Protease resistant urokinase
Grant 5,219,569 - Blaber , et al. June 15, 1 | 1993-06-15 |
| 